Therapeutic RNA manipulation in liver disease

Thomas A. Kerr, Nicholas O. Davidson

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Posttranscriptional regulation of gene expression is increasingly recognized as a model for inherited and acquired disease. Recent work has expanded understanding of the range of mechanisms that regulate several of these distinct steps, including messenger RNA (mRNA) splicing, trafficking, and/or stability. Each of these pathways is implicated in disease pathogenesis, and each represents important avenues for therapeutic intervention. This review summarizes important mechanisms controlling mRNA processing and the regulation of mRNA degradation, including the role of microRNAs and RNA binding proteins. These pathways provide important opportunities for therapeutic targeting directed at splicing and degradation in order to attenuate genetic defects in RNA metabolism. We will highlight developments in vector development and validation for therapeutic manipulation of mRNA expression with a focus on potential applications in metabolic and immunomediated liver disease.

Original languageEnglish (US)
Pages (from-to)1055-1061
Number of pages7
JournalHepatology
Volume51
Issue number3
DOIs
StatePublished - Mar 1 2010

Fingerprint

Liver Diseases
RNA
Messenger RNA
RNA Stability
RNA-Binding Proteins
Gene Expression Regulation
Therapeutics
MicroRNAs

ASJC Scopus subject areas

  • Hepatology

Cite this

Therapeutic RNA manipulation in liver disease. / Kerr, Thomas A.; Davidson, Nicholas O.

In: Hepatology, Vol. 51, No. 3, 01.03.2010, p. 1055-1061.

Research output: Contribution to journalReview article

Kerr, Thomas A. ; Davidson, Nicholas O. / Therapeutic RNA manipulation in liver disease. In: Hepatology. 2010 ; Vol. 51, No. 3. pp. 1055-1061.
@article{851af75da61d44a2a5efbc6c4155c41e,
title = "Therapeutic RNA manipulation in liver disease",
abstract = "Posttranscriptional regulation of gene expression is increasingly recognized as a model for inherited and acquired disease. Recent work has expanded understanding of the range of mechanisms that regulate several of these distinct steps, including messenger RNA (mRNA) splicing, trafficking, and/or stability. Each of these pathways is implicated in disease pathogenesis, and each represents important avenues for therapeutic intervention. This review summarizes important mechanisms controlling mRNA processing and the regulation of mRNA degradation, including the role of microRNAs and RNA binding proteins. These pathways provide important opportunities for therapeutic targeting directed at splicing and degradation in order to attenuate genetic defects in RNA metabolism. We will highlight developments in vector development and validation for therapeutic manipulation of mRNA expression with a focus on potential applications in metabolic and immunomediated liver disease.",
author = "Kerr, {Thomas A.} and Davidson, {Nicholas O.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1002/hep.23344",
language = "English (US)",
volume = "51",
pages = "1055--1061",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Therapeutic RNA manipulation in liver disease

AU - Kerr, Thomas A.

AU - Davidson, Nicholas O.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Posttranscriptional regulation of gene expression is increasingly recognized as a model for inherited and acquired disease. Recent work has expanded understanding of the range of mechanisms that regulate several of these distinct steps, including messenger RNA (mRNA) splicing, trafficking, and/or stability. Each of these pathways is implicated in disease pathogenesis, and each represents important avenues for therapeutic intervention. This review summarizes important mechanisms controlling mRNA processing and the regulation of mRNA degradation, including the role of microRNAs and RNA binding proteins. These pathways provide important opportunities for therapeutic targeting directed at splicing and degradation in order to attenuate genetic defects in RNA metabolism. We will highlight developments in vector development and validation for therapeutic manipulation of mRNA expression with a focus on potential applications in metabolic and immunomediated liver disease.

AB - Posttranscriptional regulation of gene expression is increasingly recognized as a model for inherited and acquired disease. Recent work has expanded understanding of the range of mechanisms that regulate several of these distinct steps, including messenger RNA (mRNA) splicing, trafficking, and/or stability. Each of these pathways is implicated in disease pathogenesis, and each represents important avenues for therapeutic intervention. This review summarizes important mechanisms controlling mRNA processing and the regulation of mRNA degradation, including the role of microRNAs and RNA binding proteins. These pathways provide important opportunities for therapeutic targeting directed at splicing and degradation in order to attenuate genetic defects in RNA metabolism. We will highlight developments in vector development and validation for therapeutic manipulation of mRNA expression with a focus on potential applications in metabolic and immunomediated liver disease.

UR - http://www.scopus.com/inward/record.url?scp=77950601100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950601100&partnerID=8YFLogxK

U2 - 10.1002/hep.23344

DO - 10.1002/hep.23344

M3 - Review article

C2 - 19918970

AN - SCOPUS:77950601100

VL - 51

SP - 1055

EP - 1061

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -